Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Mar 01, 2026
War Dividend: Is General Dynamics’ (GD) Stock Built to Climb in the Iran Crisis?

War Dividend: Is General Dynamics’ (GD) Stock Built to Climb in the Iran Crisis?

General Dynamics (GD) is likely to stay biased up in the Iran war environment, with defense spending and backlog support pushing the stock gradually higher, though from already elevated levels where upside looks steady, not explosive.

General Dynamics in an Iran War Defense Cycle

General Dynamics is a diversified defense and aerospace company spanning Gulfstream business jets, combat vehicles (like the Abrams tank), IT and mission systems, and nuclear submarines through its Marine Systems segment. In 2025 it generated about 52.55 billion dollars in revenue and 4.21 billion dollars in net income, both up roughly 10–11% year over year, with EPS around 15.45 and a growing backlog reported near 118 billion dollars that provides multi‑year visibility. The stock recently trades near 357 dollars, close to a 52‑week high of 369.70 dollars, with a market cap around 96–97 billion dollars and a price‑to‑earnings ratio just above 23.

The U.S.–Iran war has triggered a classic risk‑off move in broad markets but a bid into defense: the iShares U.S. Aerospace & Defense ETF is already up about 14% in 2026, and commentary highlights that recurring maintenance and software contracts can keep cash flowing long after any single conflict ends. Barron’s notes that firms like General Dynamics are well‑positioned as submarine, shipbuilding, and land‑systems demand remain structurally strong, while the Iran strikes put additional political wind at the back of U.S. and allied defense budgets. Against this backdrop, GD’s low beta (around 0.40) and rising dividend (6 dollars annually, about a 1.7% yield) make it look like a relatively defensive way to gain exposure to a prolonged period of elevated geopolitical risk.

Key Takeaways

  • GD produces business jets, combat vehicles, IT and mission systems, and submarines, with 2025 revenue of 52.55 billion dollars, net income of 4.21 billion dollars, EPS of 15.45, and a sizable backlog near 118 billion dollars that underpins future growth.​

  • The Iran war has boosted interest in defense stocks; sector ETFs are up double digits this year and analysts emphasize that long‑duration maintenance and modernization contracts can support cash flows even after the conflict cools.

  • General Dynamics shares trade around 357 dollars, not far below a 369.70‑dollar 52‑week high, with a P/E of roughly 23 and a market cap near 96–97 billion dollars, reflecting both strong recent performance and a market willing to pay a premium for defense visibility.

  • Analyst sentiment is solid but measured: around 16–23 analysts call GD a “Buy” or “Moderate Buy,” with average 12‑month price targets ranging from about 359–376 dollars and some top targets around 395–400 dollars—implying modest single‑digit to low‑double‑digit upside from here.

  • The overall picture is of a high‑quality defense name likely to grind higher as Iran‑driven tensions and submarine/business‑jet programs support earnings, but with gains constrained by a valuation that already prices in a good chunk of that strength.

How Tickeron’s AI Tools Can Help With GD

AI‑powered platforms like Tickeron can help you navigate GD’s mix of steady fundamentals and headline‑driven sentiment. Pattern‑recognition engines can scan General Dynamics’ chart for breakouts near its 52‑week highs, pullbacks to key moving averages, and volatility spikes around Iran‑related news, then backtest how similar patterns performed during previous defense‑spending cycles. Event‑driven models that track price, volume, and sector flows can flag when GD is over‑ or under‑reacting relative to the broader defense ETF basket, providing probabilities for short‑term continuation or mean reversion rather than relying on intuition alone. Combined with fundamentals—backlog trends, analyst revisions, and valuation versus price targets—Tickeron’s AI can help you decide whether to buy GD on dips as a long‑term defense compounder or treat it as a more tactical holding during this Iran‑driven risk cycle.

Tickeron AI Perspective

 Disclaimers and Limitations

Related Ticker: GD

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


GD in upward trend: price may jump up because it broke its lower Bollinger Band on August 31, 2026

GD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where GD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GD advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 287 cases where GD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GD moved out of overbought territory on August 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GD as a result. In of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GD turned negative on August 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 58 similar instances when the indicator turned negative. In of the 58 cases the stock turned lower in the days that followed. This puts the odds of success at .

GD moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.745) is normal, around the industry mean (6.535). P/E Ratio (22.643) is within average values for comparable stocks, (57.367). Projected Growth (PEG Ratio) (2.579) is also within normal values, averaging (7.993). Dividend Yield (0.017) settles around the average of (0.017) among similar stocks. P/S Ratio (1.853) is also within normal values, averaging (19.097).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.49B. The market cap for tickers in the group ranges from 4.49 to 1.87T. SPCX holds the highest valuation in this group at 1.87T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -6%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -10%. PRZO experienced the highest price growth at 40%, while FBDT experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 6% and the average quarterly volume growth was 50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 69
Price Growth Rating: 59
SMR Rating: 78
Profit Risk Rating: 74
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
GD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an aerospace and defense company that offers a broad portfolio of products and services

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
11011 Sunset Hills Road
Phone
+1 703 876-3000
Employees
111600
Web
https://www.gd.com
Interact to see
Advertisement
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
GDDY (GoDaddy) is down more than 17% today because its 2026 revenue outlook and near‑term sales guidance came in below Wall Street expectations, reinforcing worries about slowing growth and intense AI‑driven competition even though Q4 2025 headline results were solid.
For the first half of fiscal 2026, organic net sales and adjusted EPS both declined about 3% year over year and missed analyst expectations, with U.S. spirits and Chinese white spirits particularly weak. Management cut full‑year 2026 guidance again, now expecting organic sales to fall 2–3% and organic operating profit to be flat to up only low single digits, versus a prior outlook of flat to slightly down sales and low‑ to mid‑single‑digit profit growth.
DRVN (Driven Brands) is down more than 36% today because the company disclosed serious errors in its past financial statements, is delaying its Q4 2025 earnings release, and will have to restate results for the last two fiscal years, which shattered investor confidence and raised concerns about leverage and profitability.
Q4 2025 revenue was strong at about 257–258 million (up roughly 16% year over year and above forecasts), but adjusted EPS was 0.30 versus about 0.31–0.32 expected, and EBITDA of about 101–102 million was a touch below consensus.
Q4 2025 revenue was about 392 million, roughly 10–20% below consensus (around 430–440 million), and EPS came in at −0.44−0.44 versus forecasts near −0.27−0.27 to −0.32−0.32, a more than 60% negative surprise. Results were hit by a roughly 170 million non‑cash impairment plus weaker realized pricing and volumes, driving a large net loss in the quarter despite strong full‑year EBITDA and free cash flow.
AXON surged approximately +17.56% on February 25, 2026, closing at $520.18 versus the prior session's close of $442.51. The primary catalyst was a blowout Q4 2025 earnings report, with adjusted EPS of $2.15 crushing the consensus estimate of approximately $1.67.
CAVA shares surged approximately +25.01% on February 25, 2026, closing near $84.76, up from the prior session's close of $67.80. The primary catalyst was a better-than-expected Q4 fiscal 2025 earnings report, with EPS of $0.04 beating the $0.03 consensus estimate and revenue of ~$274.99M exceeding the $268.04M estimate.
ODD shares plunged approximately 49.21% on February 25, 2026, closing near $14.74, compared to the prior close of approximately $29.02. The primary catalyst was a shock Q1 2026 revenue warning: management guided for a roughly 30% year-over-year revenue decline due to a severe spike in customer acquisition costs (CAC).
MNKD shares collapsed 36.82% on February 25, 2026, closing at $3.50 versus the prior session's close of $5.54 — one of the largest single-day declines in the stock's recent history. The primary catalyst was United Therapeutics' surprise unveiling of Tresmi, a proprietary soft mist inhaler delivering treprostinil, announced during the company's Q4 2025 earnings call.
EOSE shares fell sharply on February 26, 2026, dropping approximately 31% from the prior session's close of $11.13 to around $7.64 in early trading, following a pre-market earnings release. Primary catalyst: Eos Energy reported Q4 2025 non-GAAP EPS of -$0.72, missing analyst consensus estimates by $0.48, a 200%+ negative surprise.
ARRY beat Q4 revenue expectations but showed a sharp year‑over‑year sales decline and a sizeable net loss. Adjusted EBITDA for Q4 badly missed Wall Street estimates, highlighting ongoing margin and cost pressures. 2026 guidance for EPS and EBITDA came in well below analyst forecasts, signaling weaker‑than‑hoped earnings power over the next year.
C3.ai (AI) dropped more than 18% today after delivering a deeply disappointing quarterly report, slashing its revenue outlook, and announcing mass layoffs, which together reinforced doubts about its growth story in an increasingly competitive AI software market.
On the surface, PRCT’s top line still grew: Q4 2025 revenue reached about 76.4 million dollars, up roughly 11.9–12% from the prior year. However, analysts had expected something closer to 94–96 million dollars, so the shortfall of nearly 20% was significant for a high‑growth med‑tech name.
Payoneer Global (PAYO) fell more than 18% today after it missed Wall Street expectations on both Q4 2025 revenue and earnings, and issued softer‑than‑hoped guidance that reinforced concerns about slowing growth and competitive pressure in cross‑border fintech.
Gold, uranium, and rare earth stocks are moving fast in 2026 — and this 15-minute AI Trading Agent is built to move faster. Designed for high-beta Mining & Metals leaders like NEM, LEU, MP, and KGC, it transforms commodity volatility into structured, data-driven opportunity with institutional-grade risk control.